A new drug that appears to remove an Alzheimer's disease-related protein from the blood and brain has been developed by U.K. scientists.
The drug, called CPHPC, targets the protein serum amyloid P component (SAP), which is found in the harmful plaques and tangles of nerve fibers found in the brains of Alzheimer's patients, BBC News reported.
SAP disappeared from the blood and brains of five Alzheimer's patients after three months of treatment with CPHPC, said the University College London researchers.
The findings were reported in the journal Proceedings of the National Academy of Sciences. Larger and longer clinical trials of the drug are being planned, BBC News reported.